Detalhe da pesquisa
1.
Leishmania Uses Mincle to Target an Inhibitory ITAM Signaling Pathway in Dendritic Cells that Dampens Adaptive Immunity to Infection.
Immunity
; 45(4): 788-801, 2016 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-27742545
2.
DNA flowerstructure co-localizes with human pathogens in infected macrophages.
Nucleic Acids Res
; 48(11): 6081-6091, 2020 06 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-32402089
3.
Mannose-Decorated Dendritic Polyglycerol Nanocarriers Drive Antiparasitic Drugs To Leishmania infantum-Infected Macrophages.
Pharmaceutics
; 12(10)2020 Sep 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32987800
4.
Subcutaneous Immunization of Leishmania HSP70-II Null Mutant Line Reduces the Severity of the Experimental Visceral Leishmaniasis in BALB/c Mice.
Vaccines (Basel)
; 8(1)2020 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32210040
5.
A chronic bioluminescent model of experimental visceral leishmaniasis for accelerating drug discovery.
PLoS Negl Trop Dis
; 13(2): e0007133, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30763330
6.
Polyamine transport in parasites: a potential target for new antiparasitic drug development.
Comp Biochem Physiol C Toxicol Pharmacol
; 140(2): 151-64, 2005 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-15907761